Accreditation Statement
Educational Concepts Group, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Educational Concepts Group, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Educational Concepts Group, LLC is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Educational Concepts Group, LLC designates this continuing education activity for 1.0 contact hour (0.10 CEU) (UAN 0199-0000-11-019-H01-P).
Type of activity: Knowledge-based
There are no fees for participating and receiving CME/CE credit for this activity. During the period Tuesday, July 12, 2011 through Wednesday, July 11, 2012, participants must 1) read the educational objectives and faculty disclosures; 2) study the educational activity; 3) complete the post-activity assessment.
Physicians and pharmacists who complete the post-activity assessment with a score of 70% or better may view and print their credit letter or statement of credit via the website, www.educationalconcepts.net.
|
It is the policy of ECG that the faculty, authors, planners, and other persons who may influence content of this CME/CE activity disclose all relevant financial relationships with commercial interests in order to allow ECG to identify and resolve any potential conflicts of interest.
The Following Faculty Members Have Declared Relevant Financial Relationships
| Gregory A. Otterson, MD, FACP |
Grants/Research Support |
Celgene Corporation
Genentech
Pfizer Inc
Tragara Pharmaceuticals, Inc. |
| Consultant Fees |
Celgene Corporation
Genentech |
| Heather Wakelee, MD |
Grants/Research Support |
AstraZeneca
Bayer HealthCare Pharmaceuticals, Inc.
Exelixis, Inc.
Genentech
Lilly USA, LLC
Novartis
Pfizer Inc
Regeneron Pharmaceuticals, Inc. |
Staff Disclosure
Planners and managers at ECG have no relevant financial relationships to disclose.
|
The editors wish to thank Lea Ann Hansen, PharmD, BCOP, for assistance in writing this document.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ECG does not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity do not necessarily represent the views of ECG. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Please refer to the official prescribing information for each product or consult the Physicians’ Desk Reference for discussion of approved indications, contraindications, and warnings.
This activity is supported by educational grants from the following: Agennix AG, Celgene Corporation, Genentech BioOncology, Teva Pharmaceuticals, OSI Pharmaceuticals, Inc.
For further information, please contact:
Educational Concepts Group, LLC
1300 Parkwood Circle SE, Suite 325
Atlanta, Georgia 30339
Phone: 1.866.933.1681
Fax: 1.866.933.1692
www.educationalconcepts.net
None of the contents may be reproduced in any form without prior written permission from the publisher. This activity may be accessed at www.educationalconcepts.net.
